Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Pharma
Sanofi is going all in on Dupixent's next potential nod in COPD
Ahead of an FDA action date this summer, Sanofi is prepping for Dupixent's potential debut in its next "major growth pillar," CEO Paul Hudson said.
Fraiser Kansteiner
Apr 25, 2024 12:37pm
Sanofi's Zantac settlement is worth $100M: Bloomberg
Apr 22, 2024 2:06pm
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
Sanofi restructures US commercial vaccine group
Apr 18, 2024 3:54pm
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
FDA weighs another approvable myeloma endpoint. What's at stake?
Apr 9, 2024 9:00am